4553 TOWA PHARMACEUTICAL CO.,LTD.東和薬品TSE Prime / Pharmaceuticals
0 posts
TOWA PHARMACEUTICAL CO.,LTD. (4553) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
TOWA PHARMACEUTICAL CO.,LTD. (4553) Stock Price History
TOWA PHARMACEUTICAL CO.,LTD. closed at ¥3,260 on Nov 20, 2026, −9.1% over 1 month, +8.7% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥90,934 today (−9.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −9.1%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥3,260 | −75 | −2.25% |
| Nov 19 (Thu) | ¥3,335 | −55 | −1.62% |
| Nov 18 (Wed) | ¥3,390 | +0 | +0.00% |
| Nov 17 (Tue) | ¥3,390 | −50 | −1.45% |
| Nov 16 (Mon) | ¥3,440 | +95 | +2.84% |
| Nov 13 (Fri) | ¥3,345 | −35 | −1.04% |
| Nov 12 (Thu) | ¥3,380 | −80 | −2.31% |
| Nov 11 (Wed) | ¥3,460 | −45 | −1.28% |
| Nov 10 (Tue) | ¥3,505 | +130 | +3.85% |
| Nov 9 (Mon) | ¥3,375 | +65 | +1.96% |
If you had invested ¥100,000 3 months ago, it would be worth ¥84,347 today (−15.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −15.7%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥3,260 | −75 | −2.25% |
| Nov 19 (Thu) | ¥3,335 | −55 | −1.62% |
| Nov 18 (Wed) | ¥3,390 | +0 | +0.00% |
| Nov 17 (Tue) | ¥3,390 | −50 | −1.45% |
| Nov 16 (Mon) | ¥3,440 | +95 | +2.84% |
| Nov 13 (Fri) | ¥3,345 | −35 | −1.04% |
| Nov 12 (Thu) | ¥3,380 | −80 | −2.31% |
| Nov 11 (Wed) | ¥3,460 | −45 | −1.28% |
| Nov 10 (Tue) | ¥3,505 | +130 | +3.85% |
| Nov 9 (Mon) | ¥3,375 | +65 | +1.96% |
If you had invested ¥100,000 6 months ago, it would be worth ¥84,347 today (−15.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −15.7%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥3,260 | −7.4% |
| Oct 2026 | ¥3,520 | −2.9% |
| Sep 2026 | ¥3,625 | −6.8% |
| Aug 2026 | ¥3,890 | −2.9% |
| Jul 2026 | ¥4,005 | +5.0% |
| Jun 2026 | ¥3,815 | −3.4% |
| May 2026 | ¥3,950 | −0.3% |
If you had invested ¥100,000 1 year ago, it would be worth ¥108,667 today (+8.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved +8.7%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥3,260 | −7.4% |
| Oct 2026 | ¥3,520 | −2.9% |
| Sep 2026 | ¥3,625 | −6.8% |
| Aug 2026 | ¥3,890 | −2.9% |
| Jul 2026 | ¥4,005 | +5.0% |
| Jun 2026 | ¥3,815 | −3.4% |
| May 2026 | ¥3,950 | −0.3% |
| Apr 2026 | ¥3,960 | −1.1% |
| Mar 2026 | ¥4,005 | −9.2% |
| Feb 2026 | ¥4,410 | +22.7% |
| Jan 2026 | ¥3,595 | −1.2% |
| Dec 2025 | ¥3,640 | +11.5% |
| Nov 2025 | ¥3,265 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥131,824 today (+31.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved +31.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥3,260 | −10.4% |
| 2025 | ¥3,640 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥117,098 today (+17.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved +17.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥3,260 | −10.4% |
| 2025 | ¥3,640 | ― |
If you had invested ¥100,000 in May 2004, it would be worth ¥428,009 today (+328.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +375.9%, while this stock moved +328.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥3,260 | −10.4% |
| 2025 | ¥3,640 | +8.5% |
| 2024 | ¥3,355 | +42.6% |
| 2023 | ¥2,352 | +10.4% |
| 2022 | ¥2,131 | −25.6% |
| 2021 | ¥2,864 | +49.6% |
| 2020 | ¥1,914 | −32.7% |
| 2019 | ¥2,846 | +11.3% |
| 2018 | ¥2,557 | +24.7% |
| 2017 | ¥2,050 | +34.3% |
| 2016 | ¥1,527 | −39.4% |
| 2015 | ¥2,520 | +41.0% |
| 2014 | ¥1,787 | +21.4% |
| 2013 | ¥1,472 | −2.5% |
| 2012 | ¥1,510 | +37.9% |
| 2011 | ¥1,095 | −27.2% |
| 2010 | ¥1,503 | +4.9% |
| 2009 | ¥1,433 | +8.6% |
| 2008 | ¥1,320 | −16.3% |
| 2007 | ¥1,577 | +21.9% |
| 2006 | ¥1,293 | +45.3% |
| 2005 | ¥890 | +16.3% |
| 2004 | ¥765 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from May 2004). Please check the latest prices before trading.
TOWA PHARMACEUTICAL CO.,LTD. (4553) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of TOWA PHARMACEUTICAL CO.,LTD. (4553)
Business overview
The company's main business is making and selling prescription drugs, mainly generic drugs. Its two segments are domestic and overseas. In Japan, it sells drugs it makes directly to medical institutions through its sales offices and also sells to agents, pharmaceutical wholesalers and other drug makers. Subsidiaries take on product trading and manufacturing, research and manufacturing of active ingredients, and soft capsule manufacturing on contract, and 「三生医薬」 plans, develops and contract-manufactures health foods, pharmaceuticals and more. Overseas, group companies of Towa Pharma International Holdings, S.L., a holding company that brings together its generic drug businesses in Europe and the Americas, have R&D and manufacturing bases in Europe and run generic drug sales and contract R&D and manufacturing.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 2.61% | No. 25 in the sector (highest first); median 2.97% |
|---|---|---|
| PER | 7.6x | Below the sector median of 16.5x (No. 2 from the lowest) |
| PBR | 0.84x | Below the sector median of 1.86x (No. 13 from the lowest) |
| ROE | 11.05% | No. 12 in the sector (highest first); median 4.17% |
| Market cap | ¥160.5 bn | No. 18 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥4,410 | 2/27 |
|---|---|---|
| 52-week low | ¥3,000 | 2025/11/20 |
| Current position | 18.4% | Where the low is 0% and the high is 100% (close on 11/20: ¥3,260) |
| Year to date | -10.4% | No. 38 of 77 in the sector (best first) |
| 1 year | +8.7% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/11 15:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
- 11/11 15:302027年3月期 第2四半期(中間期)決算補足説明資料
- 11/11 15:30営業外費用(デリバティブ評価損)の計上に関するお知らせ
- 10/30 15:30(開示事項の変更)田辺ファーマ株式会社からの田辺ファーマファクトリー株式会社の株式の取得(完全子会社化)に係る株式譲渡実行日の変更に関するお知らせ
Filings from the past 12 months (4).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the TOWA PHARMACEUTICAL CO.,LTD. board
More Japanese stocks in English
- Fuji Pharma Co.,Ltd.4554
- CHUKYO IYAKUHIN CO.,LTD.4558
- ZERIA PHARMACEUTICAL CO.,LTD.4559
- Value Soft Holdings Corporation455A
- AnGes,Inc.4563
- OncoTherapy Science,Inc.4564
- Nxera Pharma Co.,Ltd.4565
- KYORIN Pharmaceutical Co.,Ltd.4569
- HUMAN MADE Inc.456A
- Immuno-Biological Laboratories Co.,Ltd.4570
- Nano Holdings,Inc.4571
- Carna Biosciences,Inc.4572